Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

1 September 2026

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

1 September 2026

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

1 September 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

31 August 2026

Pzena Focused Credit Opportunities Q2 2026 Commentary

31 August 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 1
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » ‘No Idea’ Investing: I Built A Concentrated, Fundamentals-Based Portfolio Using Algorithms
News

‘No Idea’ Investing: I Built A Concentrated, Fundamentals-Based Portfolio Using Algorithms

thebusinesstimes.co.ukBy thebusinesstimes.co.uk14 June 20264 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
‘No Idea’ Investing: I Built A Concentrated, Fundamentals-Based Portfolio Using Algorithms
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

Yuval Taylor is a hedge fund manager, author, and analyst who has been using multifactor ranking systems to buy and sell stocks since 2015. He focuses on microcaps and emphasizes evaluating every stock from as many angles as possible via algorithm. He is the leader of the investing group The Stock Evaluator.Features of the service include a spreadsheet of nearly 10,000 stocks rated from 0 to 100 weekly and live chat for questions. Learn more

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

Pzena Focused Credit Opportunities Q2 2026 Commentary

Virtus KAR Small-Cap Growth Fund Q2 2026 Commentary

Ensurge Micropower ASA (ENMPF) Q2 2026 Earnings Call Transcript

Weekly Closed-End Fund Roundup (August 23, 2026)

Baron Generational Growth Fund Q2 2026 Portfolio Activity

Editors Picks

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

1 September 2026

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

1 September 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

31 August 2026

Pzena Focused Credit Opportunities Q2 2026 Commentary

31 August 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Virtus KAR Small-Cap Growth Fund Q2 2026 Commentary

31 August 2026

Ensurge Micropower ASA (ENMPF) Q2 2026 Earnings Call Transcript

31 August 2026

Weekly Closed-End Fund Roundup (August 23, 2026)

31 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.